Thomas A. Mccourt - 10 Mar 2026 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: IRWD
Reported as of: 10 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Mar 2026, 16:05:04 UTC
Prior SEC filing: 25 Feb 2026
Next SEC filing: 12 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Amir Vitale, Attorney-in-Fact

Key filing fact

Thomas A. Mccourt filed Form 4 for IRONWOOD PHARMACEUTICALS INC (IRWD) on 12 Mar 2026.

Key facts

This page summarizes Thomas A. Mccourt's Form 4 filing for IRONWOOD PHARMACEUTICALS INC (IRWD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Mar 2026, 16:05.

Change

Previous filing in this sequence was filed on 25 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001478448 Primary reporting owner

MCCOURT Thomas A

Relationship: Chief Executive Officer, Director
Address: C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON
Signature: /s/ Amir Vitale, Attorney-in-Fact
Signature date: 12 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRWD transaction

Class A Common Stock

Award

Transaction value
Shares: +409,836
Change %: +28%
Price: $0.000000^*
Shares after: 1,898,838
Date: 10 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.